Orlistat Market size is valued at USD 2,850.07 Million in 2020 and is projected to grow to USD 4,348.26 Million by 2027 with a CAGR of 6.2%. Orlistat is an anti-obesity medication. Orlistat's main function is to inhibit fat from being absorbed from the human diet. It works as a lipase inhibitor, preventing fat absorption and thereby lowering calorie intake. Orlistat acts by blocking the enzymes that break down triglycerides in the intestine, pancreatic and gastric lipases. When lipase activity is inhibited, dietary triglycerides are not digested into absorbable-free fatty acids and instead remain unaltered. Orlistat also lowers blood pressure and helps obese people from developing type 2 diabetes. Orlistat does not allow you to restore weight loss and does not prevent fat absorption from non-fat foods or sweets. The Orlistat market in the legal industry has limited market penetration, which presents a huge opportunity for the existing players as well as the outsiders willing...